Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1965 2
1966 15
1967 9
1968 9
1969 9
1970 12
1971 18
1972 10
1973 16
1974 13
1975 23
1976 16
1977 25
1978 27
1979 18
1980 14
1981 15
1982 24
1983 30
1984 27
1985 20
1986 27
1987 28
1988 20
1989 33
1990 23
1991 21
1992 21
1993 35
1994 33
1995 24
1996 48
1997 30
1998 24
1999 31
2000 51
2001 26
2002 26
2003 20
2004 22
2005 20
2006 42
2007 34
2008 33
2009 37
2010 42
2011 53
2012 49
2013 38
2014 49
2015 45
2016 46
2017 29
2018 35
2019 40
2020 41
2021 35
2022 36
2023 30
2024 18
2025 26
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,528 results

Results by year

Filters applied: . Clear all
Page 1
Overall survival with daratumumab, bortezomib, melphalan, and prednisone in newly diagnosed multiple myeloma (ALCYONE): a randomised, open-label, phase 3 trial.
Mateos MV, Cavo M, Blade J, Dimopoulos MA, Suzuki K, Jakubowiak A, Knop S, Doyen C, Lucio P, Nagy Z, Pour L, Cook M, Grosicki S, Crepaldi A, Liberati AM, Campbell P, Shelekhova T, Yoon SS, Iosava G, Fujisaki T, Garg M, Krevvata M, Chen Y, Wang J, Kudva A, Ukropec J, Wroblewski S, Qi M, Kobos R, San-Miguel J. Mateos MV, et al. Lancet. 2020 Jan 11;395(10218):132-141. doi: 10.1016/S0140-6736(19)32956-3. Epub 2019 Dec 10. Lancet. 2020. PMID: 31836199 Clinical Trial.
Melphalan flufenamide for relapsed/refractory multiple myeloma.
Nadeem O, Mateos MV, Efebera YA, Paner A, Larocca A, Rodríguez-Otero P, Leleu X, Richardson PG. Nadeem O, et al. Drugs Today (Barc). 2022 Aug;58(8):407-423. doi: 10.1358/dot.2022.58.8.3367680. Drugs Today (Barc). 2022. PMID: 35983927 Review.
Melphalan-Induced Atrial Fibrillation.
Shah AJ, Kobrossi S, Desai A. Shah AJ, et al. Am J Ther. 2018 Sep/Oct;25(5):e571-e572. doi: 10.1097/MJT.0000000000000651. Am J Ther. 2018. PMID: 28816723 No abstract available.
Optimizing high dose melphalan.
Shah G, Giralt S, Dahi P. Shah G, et al. Blood Rev. 2024 Mar;64:101162. doi: 10.1016/j.blre.2023.101162. Epub 2023 Dec 10. Blood Rev. 2024. PMID: 38097487 Review.
Melphalan.
National Toxicology Program. National Toxicology Program. Rep Carcinog. 2011;12:258-9. Rep Carcinog. 2011. PMID: 21860475 Free article. No abstract available.
High-dose busulfan-melphalan vs melphalan and reinforced VRD for newly diagnosed multiple myeloma: a phase 3 GEM trial.
Lahuerta JJ, San-Miguel J, Jiménez-Ubieto A, Alonso R, Paiva B, Puig N, Cedena MT, Gutierrez NC, Calasanz MJ, Fernández Guijarro M, Tamayo RR, Rocafiguera AO, Blanchard MJ, Carrillo Cruz E, Martínez-Martínez R, Bargay J, Sureda Balari A, Rubia J, Hernández García MT, Cabañas V, Montero FC, Bernal LP, Montes YG, Martínez-Lopez J, Rodriguez-Otero P, Krisnik I, Arguiñano JM, Gonzalez García ME, Ocio EM, Cruz J, Mateos MV, Rosiñol L, Bladé J. Lahuerta JJ, et al. Blood. 2025 Oct 9;146(15):1747-1758. doi: 10.1182/blood.2025028313. Blood. 2025. PMID: 40499010 Clinical Trial.
Bortezomib, melphalan, and prednisone with or without daratumumab in transplant-ineligible patients with newly diagnosed multiple myeloma (ALCYONE): final analysis of an open-label, randomised, multicentre, phase 3 trial.
Mateos MV, San-Miguel J, Cavo M, Suzuki K, Jakubowiak A, Knop S, Doyen C, Lucio P, Nagy Z, Pour L, Grosicki S, Crepaldi A, Liberati AM, Campbell P, Yoon SS, Iosava G, Fujisaki T, Garg M, Ngo M, Katz EG, Krevvata M, Bolyard K, Carson R, Borgsten F, Dimopoulos MA. Mateos MV, et al. Lancet Oncol. 2025 May;26(5):596-608. doi: 10.1016/S1470-2045(25)00018-X. Epub 2025 Apr 9. Lancet Oncol. 2025. PMID: 40220771 Clinical Trial.
Melphalan hydrochloride for the treatment of multiple myeloma.
Esma F, Salvini M, Troia R, Boccadoro M, Larocca A, Pautasso C. Esma F, et al. Expert Opin Pharmacother. 2017 Aug;18(11):1127-1136. doi: 10.1080/14656566.2017.1349102. Epub 2017 Jul 10. Expert Opin Pharmacother. 2017. PMID: 28658983 Free article. Review.
1,528 results